{"brief_title": "Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection", "brief_summary": "The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.", "condition": ["Hepatitis B", "Chronic Disease"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["entecavir", "adefovir"], "description": ["Tablets, Oral, ETV 0.5 mg, once daily, up to 96 weeks", "Tablets, Oral, ADV 10 mg, once daily, up to 96 weeks"], "arm_group_label": ["A1", "A2"], "other_name": ["Baraclude"], "criteria": "Inclusion Criteria: - Chronic hepatitis B treatment naive - Compensated liver disease", "gender": "All", "minimum_age": "16 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "chronic hepatitis B infection", "mesh_term": ["Infection", "Hepatitis", "Hepatitis A", "Hepatitis, Chronic", "Hepatitis B", "Hepatitis B, Chronic", "Chronic Disease", "Adefovir", "Adefovir dipivoxil", "Entecavir"], "id": "NCT00096785"}